Cargando…

The delivery of therapeutic oligonucleotides

The oligonucleotide therapeutics field has seen remarkable progress over the last few years with the approval of the first antisense drug and with promising developments in late stage clinical trials using siRNA or splice switching oligonucleotides. However, effective delivery of oligonucleotides to...

Descripción completa

Detalles Bibliográficos
Autor principal: Juliano, Rudolph L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001581/
https://www.ncbi.nlm.nih.gov/pubmed/27084936
http://dx.doi.org/10.1093/nar/gkw236